AGT and cardiac hypertrophy: Echocardiography indicated that administration of p22077 sharply attenuated Ang II-induced cardiac hypertrophy and cardiac contractile dysfunction, as reflected by delaying the decrease of left ventricular (LV) ejection fraction (EF%) and fractional shortening (FS%), compared with DMSO plus Ang II-treated mice (Figures 3D–F).